Clinical Trial Update: CONTINuous Infra-Inguinal Stenting Using the Bard® LifeStent® VascUlar Stent SysteMs ("CONTINUUM") [NA]

View source ↗

Summary

Clinical trial CONTINUUM investigating stenting for superficial femoral artery stenosis was terminated with results posted later.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease
• Superficial Femoral Artery Stenosis

Drugs mentioned

• Bard LifeStent Vascular Stent System

Snippet

Sponsor: C. R. Bard | Conditions: Superficial Femoral Artery Stenosis | NA | Status: TERMINATED | Results posted: 2019-11-06